Cardiol Therapeutics (CRDL) Exchange Rate Effect (2022 - 2026)
Cardiol Therapeutics (CRDL) reported Exchange Rate Effect of $161840.6 for Q1 2026, up 315.47% on a YoY basis from $38954.1 in Q1 2025, and up 143.03% quarter-over-quarter from -$376068.7 in Q4 2025.
Cardiol Therapeutics (CRDL) Exchange Rate Effect (2022 - 2026) Analysis & Trends
Cardiol Therapeutics has reported Exchange Rate Effect for 5 years, with the latest figure at $161840.6 in Q1 2026.
- For the quarter ending Q1 2026, Exchange Rate Effect rose 315.47% year-over-year to $161840.6; the trailing twelve-month figure through Mar 2026 stood at -$350851.6 (down 138.03% YoY), and the FY2025 full-year result was -$590908.5, down 143.67% from the prior year.
- Exchange Rate Effect for Q1 2026 stood at $161840.6, up from -$376068.7 in the prior quarter.
- The five-year high for Exchange Rate Effect was $4.8 million in Q4 2022, with the low at -$2.5 million in Q3 2022.
- Historically, Exchange Rate Effect has averaged $207947.0 across 5 years, with a median of $109437.8 in 2024.
- Annual changes were most pronounced in 2024 — Exchange Rate Effect jumped 17751.51% — and 2025, when it sank 470.0%.
- Cardiol Therapeutics' Exchange Rate Effect stood at $4.8 million in 2022, then slumped by 86.58% to $647090.5 in 2023, then soared by 77.44% to $1.1 million in 2024, then plunged by 132.75% to -$376068.7 in 2025, then jumped by 143.03% to $161840.6 in 2026.
- The last three Exchange Rate Effect figures came in at $161840.6 (Q1 2026), -$376068.7 (Q4 2025), and $268294.7 (Q3 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Exchange Rate Effect (Qtr) |
|---|---|---|---|---|---|
| 1 | Teva Pharmaceutical Industries | 39.72 Bn | 35.98 Bn | 1.97 Bn | -17.00 Mn |
| 2 | Zoetis | 34.61 Bn | 32.67 Bn | 1.62 Bn | 17.00 Mn |
| 3 | United Therapeutics | 24.07 Bn | 21.91 Bn | 648.10 Mn | - |
| 4 | Aurora Cannabis | 16.98 Bn | 16.91 Bn | 33.43 Mn | - |
| 5 | Neurocrine Biosciences | 16.64 Bn | 15.32 Bn | 800.70 Mn | - |
| 6 | Elanco Animal Health | 12.19 Bn | 11.76 Bn | 785.00 Mn | -5.00 Mn |
| 7 | Alkermes | 7.37 Bn | 6.86 Bn | -116.06 Mn | - |
| 8 | Hims & Hers Health | 6.62 Bn | 5.87 Bn | 396.79 Mn | -2.38 Mn |
| 9 | Lantheus Holdings | 6.47 Bn | 5.97 Bn | 230.92 Mn | -22,000.00 |
| 10 | Cardiol Therapeutics | 168.37 Mn | 148.19 Mn | - | 161,840.64 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 161,840.64 |
| Mar 31, 2026 | 161,840.64 |
| Dec 31, 2025 | -376,068.73 |
| Dec 31, 2025 | -376,068.73 |
| Sep 30, 2025 | 268,294.72 |
| Sep 30, 2025 | 268,294.72 |
| Jun 30, 2025 | -404,918.24 |
| Jun 30, 2025 | -404,918.24 |
| Mar 31, 2025 | -75,112.26 |
| Mar 31, 2025 | -75,112.26 |
| Dec 31, 2024 | 1.15 Mn |
| Dec 31, 2024 | 1.15 Mn |
| Sep 30, 2024 | -259,981.06 |
| Sep 30, 2024 | -259,981.06 |
| Jun 30, 2024 | 109,437.85 |
| Jun 30, 2024 | 109,437.85 |
| Mar 31, 2024 | 364,449.57 |
| Mar 31, 2024 | 364,449.57 |
| Dec 31, 2023 | 647,090.54 |
| Dec 31, 2023 | 647,090.54 |